02891nam 2200613 a 450 991096233350332120200520144314.097816080547491608054748(CKB)2550000001040967(EBL)1121697(OCoLC)827207354(SSID)ssj0001355734(PQKBManifestationID)11813787(PQKBTitleCode)TC0001355734(PQKBWorkID)11348074(PQKB)10207318(MiAaPQ)EBC1121697(DE-B1597)732002(DE-B1597)9781608054749(Perlego)976737(EXLCZ)99255000000104096720130226d2013 uy 0engur|n|---|||||txtccrAdvances in cancer drug targetsVolume 1 /editor, Atta-ur-Rahman1st ed.Sharjah, United Arab Emirates ;Oak Park, Ill. Bentham Science Publishers[2013?]1 online resource (316 p.)Advances in cancer drug targets,2213-9915 ;v. 1Description based upon print version of record.9781608056019 1608056015 Includes bibliographical references and index.Title; EUL; Contents; Foreword; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; IndexAdvances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.Advances in Cancer Drug TargetsCancerChemotherapyDrug targetingCancerChemotherapy.Drug targeting.615/.19Rahman Atta-ur, authttp://id.loc.gov/vocabulary/relators/aut544456Rahman Atta-ur-1942-544456MiAaPQMiAaPQMiAaPQBOOK9910962333503321Advances in cancer drug targets4345117UNINA